Ad is loading...
MENU
ITRM
AS OF
Nov 15 closing price
Price
$1.37
Change
+$0.01 (+0.74%)
Capitalization
31.11M
134 days until earnings call
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2024 All rights reserved. Tickeron Inc.

ITRM Stock ITRM is expected to report earnings to rise+42% to -17 cents per share on November 14

TickeronGET DAILY SIGNALS
A.I.dvisor
at Tickeron.com
Loading...
ITRM - Iterum Therapeutics plc
Iterum Therapeutics plc Earnings Graph
Q3'24
Est.
$-0.17
Q2'24
Beat
by $0.15
Q1'24
Beat
by $0.33
Q4'23
Beat
by $0.11
Q3'23
Beat
by $0.58
The last earnings report on June 30 showed earnings per share of -30 cents, beating the estimate of -45 cents. P/B Ratio (0.000) is normal, around the industry mean (13.983). P/E Ratio (0.000) is within average values for comparable stocks, (100.519). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.946). ITRM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (223.316). With 1.39M shares outstanding, the current market capitalization sits at 33.60M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an operator, which engages in the healthcare industry focusing on biotechnology business

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
Fitzwilliam Court
Phone
+353 16694820
Employees
14
Web
https://www.iterumtx.com